{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:31:02Z","timestamp":1790803862891,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-38946-1","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T15:24:45Z","timestamp":1770650685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Design, synthesis, and antitumor evaluation of new functionalized spiroindenopyridotriazinepyrans"],"prefix":"10.1038","volume":"16","author":[{"given":"Fatemeh","family":"Safari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5235-1203","authenticated-orcid":false,"given":"Mohammad","family":"Bayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajar","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atefeh","family":"Homaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"38946_CR1","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1021\/jacs.2c11071","volume":"145","author":"Q Guan","year":"2023","unstructured":"Guan, Q., Zhou, L. L. & Dong, Y. B. Construction of covalent organic frameworks via multicomponent reactions. J. Am. Chem. Soc. 145, 1475\u20131496. https:\/\/doi.org\/10.1021\/jacs.2c11071 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"38946_CR2","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1002\/chem.200802140","volume":"15","author":"JD Sunderhaus","year":"2009","unstructured":"Sunderhaus, J. D. & Martin, S. F. Applications of multicomponent reactions to the synthesis of diverse heterocyclic scaffolds. Chem. Eur. J. 15, 1300\u20131308. https:\/\/doi.org\/10.1002\/chem.200802140 (2009).","journal-title":"Chem. Eur. J."},{"key":"38946_CR3","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1039\/D0QO01480J","volume":"8","author":"SE John","year":"2021","unstructured":"John, S. E., Gulati, S. & Shankaraiah, N. Recent advances in multicomponent reactions and their mechanistic insights: a triennium review. Org. Chem. Front. 8, 4237\u20134287. https:\/\/doi.org\/10.1039\/D0QO01480J (2021).","journal-title":"Org. Chem. Front."},{"key":"38946_CR4","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1039\/C2GC16388H","volume":"14","author":"LR Wen","year":"2012","unstructured":"Wen, L. R., Li, Z. R., Li, M. & Cao, H. Solvent-free and efficient synthesis of imidazo[1,2-a]pyridine derivatives via a one-pot three-component reaction. Green. Chem. 14, 707\u2013716. https:\/\/doi.org\/10.1039\/C2GC16388H (2012).","journal-title":"Green. Chem."},{"key":"38946_CR5","doi-asserted-by":"publisher","first-page":"7134","DOI":"10.1002\/anie.200601872","volume":"45","author":"C Nicolaou","year":"2006","unstructured":"Nicolaou, C., Edmonds, D. J. & Bulger, P. G. Cascade reactions in total synthesis. Angew Chem. Int. Ed. 45, 7134\u20137186. https:\/\/doi.org\/10.1002\/anie.200601872 (2006).","journal-title":"Angew Chem. Int. Ed."},{"key":"38946_CR6","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1016\/j.bmcl.2014.06.081","volume":"24","author":"Y Zheng","year":"2014","unstructured":"Zheng, Y., Tice, C. M. & Singh, S. B. The use of spirocyclic scaffolds in drug discovery. Bioorg. Med. Chem. Lett. 24, 3673\u20133682. https:\/\/doi.org\/10.1016\/j.bmcl.2014.06.081 (2014).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"38946_CR7","doi-asserted-by":"publisher","first-page":"112577","DOI":"10.1016\/j.ejmech.2020.112577","volume":"203","author":"C Chen","year":"2020","unstructured":"Chen, C. & He, L. Advances in research of spirodienone and its derivatives: biological activities and synthesis methods. Eur. J. Med. Chem. 203, 112577. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112577 (2020).","journal-title":"Eur. J. Med. Chem."},{"key":"38946_CR8","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1080\/17460441.2016.1195367","volume":"11","author":"YJ Zheng","year":"2016","unstructured":"Zheng, Y. J. & Tice, C. M. The utilization of spirocyclic scaffolds in novel drug discovery. Expert Opin. Drug Discov. 11, 831\u2013834. https:\/\/doi.org\/10.1080\/17460441.2016.1195367 (2016).","journal-title":"Expert Opin. Drug Discov"},{"key":"38946_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/17460441.2022.2055544","volume":"17","author":"VF Batista","year":"2022","unstructured":"Batista, V. F., Pinto, D. C. G. A. & Silva, A. M. S. Recent in vivo advances of spirocyclic scaffolds for drug discovery. Expert Opin. Drug Dis. 17, 603\u2013618. https:\/\/doi.org\/10.1080\/17460441.2022.2055544 (2022).","journal-title":"Expert Opin. Drug Dis."},{"key":"38946_CR10","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1080\/17460441.2016.1195367","volume":"11","author":"YJ Zheng","year":"2016","unstructured":"Zheng, Y. J. & Tice, C. M. The utilization of spirocyclic scaffolds in novel drug discovery. Expert Opin. Drug Dis. 11, 831\u2013834. https:\/\/doi.org\/10.1080\/17460441.2016.1195367 (2016).","journal-title":"Expert Opin. Drug Dis."},{"key":"38946_CR11","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1016\/j.bmcl.2014.06.081","volume":"24","author":"Y Zheng","year":"2014","unstructured":"Zheng, Y., Tice, C. M. & Singh, S. B. The use of spirocyclic scaffolds in drug discovery. Bioor Med. Chem. Lett. 24, 3673\u20133682. https:\/\/doi.org\/10.1016\/j.bmcl.2014.06.081 (2014).","journal-title":"Bioor Med. Chem. Lett."},{"key":"38946_CR12","doi-asserted-by":"publisher","first-page":"21926","DOI":"10.1039\/D1RA01170G","volume":"11","author":"K Acosta-Quiroga","year":"2021","unstructured":"Acosta-Quiroga, K., Rojas-Pe\u00f1a, C., Nerio, L. S., Guti\u00b4errez, M. & Polo-Cuadrado, E. Spirocyclic derivatives as antioxidants: a review. RSC Adv. 11, 21926\u201321954. https:\/\/doi.org\/10.1039\/D1RA01170G (2021).","journal-title":"RSC Adv."},{"issue":"68","key":"38946_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.24959\/ophcj.19.182954","volume":"4","author":"GV Grygoriv","year":"2019","unstructured":"Grygoriv, G. V. et al. Spiro[benzo[\u0435]pyrano[3,2-c][1,2]oxathiin-4,3\u2019-indolil]-3-carbonitrile 5,5-dioxides: synthesis and the biological activity study. J. Org. Pharm. Chem. 4 (68), 53\u201361. https:\/\/doi.org\/10.24959\/ophcj.19.182954 (2019).","journal-title":"J. Org. Pharm. Chem."},{"key":"38946_CR14","doi-asserted-by":"publisher","first-page":"16794","DOI":"10.1021\/acsomega.9b01571","volume":"4","author":"M Saigal","year":"2019","unstructured":"Saigal, M., Irfan, P., Khan, M. & Khan, M. M. Design, synthesis, and biological evaluation of novel fused spiro\u20134H\u2013pyran derivatives as bacterial biofilm disruptor. ACS Omega. 4, 16794\u201316807. https:\/\/doi.org\/10.1021\/acsomega.9b01571 (2019).","journal-title":"ACS Omega"},{"key":"38946_CR15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1021\/acs.jmedchem.0c01473","volume":"64","author":"K Hiesinger","year":"2021","unstructured":"Hiesinger, K., Dar\u2019in, D., Proschak, E. & Krasavin, M. Spirocyclic scaffolds in medicinal chemistry. J. Med. Chem. 64, 150\u2013183. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01473 (2021).","journal-title":"J. Med. Chem."},{"key":"38946_CR16","doi-asserted-by":"publisher","first-page":"10130","DOI":"10.1021\/ja051147z","volume":"127","author":"NNN Ding","year":"2005","unstructured":"Ding, N. N. N. et al. Structure-based design of potent non-peptide MDM2 inhibitors. J. Am. Chem. Soc. 127, 10130\u201310131. https:\/\/doi.org\/10.1021\/ja051147z (2005).","journal-title":"J. Am. Chem. Soc."},{"key":"38946_CR17","doi-asserted-by":"publisher","first-page":"27131","DOI":"10.1039\/C8RA05690K","volume":"8","author":"H Hosseini","year":"2018","unstructured":"Hosseini, H. & Bayat, M. An efficient and ecofriendly synthesis of highly functionalized pyridones via a one-pot three-component reaction. RSC Adv. 8, 27131\u201327143. https:\/\/doi.org\/10.1039\/C8RA05690K (2018).","journal-title":"RSC Adv."},{"key":"38946_CR18","doi-asserted-by":"publisher","first-page":"31488","DOI":"10.1039\/D3RA06248A","volume":"13","author":"M Rezaei","year":"2023","unstructured":"Rezaei, M. & Bayat, M. Efficient synthesis of new indenopyridotriazine[4.3.3]propellanes and spiroindenopyridotriazine-4H-pyran derivatives. RSC Adv. 13, 31488\u201331496. https:\/\/doi.org\/10.1039\/D3RA06248A (2023).","journal-title":"RSC Adv."},{"key":"38946_CR19","doi-asserted-by":"publisher","first-page":"24843","DOI":"10.1039\/C9RA03196K","volume":"9","author":"F Safari","year":"2019","unstructured":"Safari, F., Hosseini, H., Bayat, M. & Ranjbar, A. Synthesis and evaluation of antimicrobial activity, cytotoxic and pro-apoptotic effects of novel spiro-4H-pyran derivatives. RSC Adv. 9, 24843\u201324851. https:\/\/doi.org\/10.1039\/C9RA03196K (2019).","journal-title":"RSC Adv."},{"key":"38946_CR20","doi-asserted-by":"publisher","unstructured":"Sadeghian, Z., Bayat, M. & Safari, F. Synthesis and in vitro anticancer activity evaluation of spiro[indolo[2,1-b]quinazoline-pyrano[2,3-c]pyrazole] via sequential four-component reaction. J. Mol. Struct. 1250:131759. https:\/\/doi.org\/10.1016\/j.molstruc.2021.131759","DOI":"10.1016\/j.molstruc.2021.131759"},{"key":"38946_CR21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00044-022-02856-4","volume":"31","author":"Z Sadeghian","year":"2022","unstructured":"Sadeghian, Z., Bayat, M. & Safari, F. Synthesis and antitumor activity screening of Spiro tryptanthrin-based heterocyclic compounds. Med. Chem. Res. 31, 497\u2013506. https:\/\/doi.org\/10.1007\/s00044-022-02856-4 (2022).","journal-title":"Med. Chem. Res."},{"key":"38946_CR22","doi-asserted-by":"publisher","first-page":"101636","DOI":"10.1016\/j.rechem.2024.101636","volume":"9","author":"Z Sadeghian","year":"2024","unstructured":"Sadeghian, Z., Bayat, M., Eskandari, M. & Safari, F. TCAA-promoted novel approach synthesis and in vitro anti-cancer activity evaluation of spiro[indolo[2,1-b]quinazoline-6,4\u2032-pyrano[2,3-c]pyrazole]-5\u2032-carboxamides. Results Chem. 9, 101636. https:\/\/doi.org\/10.1016\/j.rechem.2024.101636 (2024).","journal-title":"Results Chem."},{"key":"38946_CR23","doi-asserted-by":"publisher","first-page":"7103","DOI":"10.1039\/d5ra01048a","volume":"15","author":"A Homaee","year":"2025","unstructured":"Homaee, A., Bayat, M. & Hosseini, H. Multicomponent synthesis of novel functionalized spiroindenopyridotriazine-4H-pyrans. RSC Adv. 15, 7103\u20137110. https:\/\/doi.org\/10.1039\/d5ra01048a (2025).","journal-title":"RSC Adv."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38946-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38946-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38946-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:02:24Z","timestamp":1772496144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38946-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["38946"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-38946-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"27 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7917"}}